Light-Activated Rhenium Complexes with Dual Mode of Action against Bacteria.

Chemistry

Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, 4072, Australia.

Published: March 2020

AI Article Synopsis

  • New antibiotics are critically needed to combat drug-resistant bacteria.
  • A new light-activated rhenium complex has been created, showing effectiveness against resistant strains like S. aureus and E. coli.
  • Research indicates that this complex works through two different mechanisms, based on its effectiveness against mutant strains and how well it is taken up by cells.

Article Abstract

New antibiotics and innovative approaches to kill drug-resistant bacteria are urgently needed. Metal complexes offer access to alternative modes of action but have only sparingly been investigated in antibacterial drug discovery. We have developed a light-activated rhenium complex with activity against drug-resistant S. aureus and E. coli. The activity profile against mutant strains combined with assessments of cellular uptake and synergy suggest two distinct modes of action.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687258PMC
http://dx.doi.org/10.1002/chem.201904689DOI Listing

Publication Analysis

Top Keywords

light-activated rhenium
8
modes action
8
rhenium complexes
4
complexes dual
4
dual mode
4
mode action
4
action bacteria
4
bacteria antibiotics
4
antibiotics innovative
4
innovative approaches
4

Similar Publications

Transition metal complex-loaded nanosystems (TMCNs) represent a cutting-edge platform for stimuli (light, ultrasound)-responsive cancer therapies. These nanosystems, incorporating metals such as manganese(II), zinc(II), ruthenium(II), rhenium(I), iridium(III), and platinum(IV), significantly enhance the efficacy of light-activated therapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), as well as ultrasound-activated treatments like sonodynamic therapy (SDT). TMCNs based on ruthenium(II), rhenium(I), and iridium(III) improve PDT, while manganese(II) and iridium(III) demonstrate exceptional sonosensitizing properties.

View Article and Find Full Text PDF

This work investigates the proposed enhanced efficacy of photodynamic therapy (PDT) by activating photosensitizers (PSs) with Cherenkov light (CL). The approaches of Yoon et al. to test the effect of CL with external radiation were taken up and refined.

View Article and Find Full Text PDF
Article Synopsis
  • New antibiotics are critically needed to combat drug-resistant bacteria.
  • A new light-activated rhenium complex has been created, showing effectiveness against resistant strains like S. aureus and E. coli.
  • Research indicates that this complex works through two different mechanisms, based on its effectiveness against mutant strains and how well it is taken up by cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!